Sort
40,608 grants matching “prostate cancer”
Super Resolution for Improved Multislice Prostate MRI
$550,278Stephen J Riederer · Mayo Clinic Rochester · R01 · FY2024 · EB
Structural surfaceomics to probe conformation-selective immunotherapy targets
$550,255Arun P. Wiita · University Of California, San Francisco · R01 · FY2024 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
$550,218Michael J Thun · American Cancer Society, Inc. · U01 · FY2009 · CA
Miniaturized Real-Time Volumetric Ultrasound Imaging System
$550,216Butrus T Khuri-Yakub · Stanford University · R01 · FY2010 · CA
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER
$550,200Sidney Kimmel Cancer Center · R01 · FY2004 · CA
Targeting angiotensin and inflammation to prevent radiotherapy-induced bladder toxicity.
$550,166Brian Marples · University Of Rochester · R01 · FY2024 · CA
Characterizing Prostate Cancer By ex vivo MRS Signatures
$550,018Leo L Cheng · Massachusetts General Hospital · R01 · FY2014 · CA
Atlanta Regional Community Clinical Oncology Program
$549,987St. Joseph'S Hospital · U10 · FY2005 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells
$549,794Mauricio J. Reginato · Drexel University · U01 · FY2022 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells
$549,794Mauricio J. Reginato · Drexel University · U01 · FY2023 · CA
Novel, Noninvasive, Rapid Tumor Ablation Technology using Histotripsy
$549,773Zhen Xu · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
$549,768Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
$549,768Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer
$549,721Hui Zhang · Johns Hopkins University · U01 · FY2017 · CA
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome
$549,718Andrew J Vickers · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
PET Imaging of Cancer with pH (Low) Insertion Peptide (pHLIP)
$549,660Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Genetics of Prostate Cancer Susceptibility
$549,643Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Development of Novel Targeted Therapeutic Agents for Castration Resistant Prostate Cancer
$549,548Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2025 · CA
Quantifying and Characterizing the shared genetic contribution to common cancers
$549,469Sara Lindstroem · University Of Washington · U01 · FY2019 · CA
Southern Nevada Cancer Research Foundation--CCOP
$549,418Southern Nevada Cancer Research Fdn · U10 · FY2003 · CA
A SPECIFIC SCREENING STRATEGY TO REDUCE PROSTATE CANCER MORTALITY
$549,375University Of Alabama At Birmingham · · FY2012 · Department of the Army
Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications
$549,357Nupam P Mahajan · Washington University · R01 · FY2024 · CA
Using Prostate Health Index and MRI in Combination for Cost-effectively Detecting High-Grade Prostate Cancer in Minorities
$549,322Adam Bryant Murphy · Northwestern University At Chicago · R01 · FY2024 · CA
MicroRNAs in the Progression and Metastisis of Prostate Cancer
$549,290Rajvir Dahiya · University Of California, San Francisco · R01 · FY2010 · CA
Outcomes of Prostate Cancer Androgen Deprivation Therapy
$549,086Arnold L Potosky · Georgetown University · R01 · FY2012 · CA